课题基金 / 基金详情

项目摘要

项目成果

Heidi Kong的其他基金

相似基金

相关文献

中文摘要
翻译
在2013财年,我们继续评估与分子靶向治疗相关的肿瘤患者的皮肤毒性风险。这些评估包括治疗开始前的基线评估和监测和治疗这些皮肤毒性的随访。我们与肿瘤学同事合作,优化设计治疗方案,以评估皮肤毒性,并告知研究社区潜在的新描述的皮肤毒性和管理这些不良反应的方法,以优化肿瘤患者的持续抗肿瘤治疗。
英文摘要
In fiscal year 2013, we continued to evaluate oncology patients at risk for the development of cutaneous toxicities associated with molecularly targeted therapies. These evaluations included baseline evaluations prior to initiation of treatment and follow-up visits to monitor and treat these skin toxicities. We work with oncology colleagues to optimally design treatment protocols to evaluate for cutaneous toxicities and to inform the research community of potentially newly described skin toxicities and methods for management of these adverse effects to optimize continued antineoplastic treatment of oncology patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of systemic and topical perturbations on human microbes
Botulinum Toxin for Painful Cutaneous Leiomyomas
Gene Expression Profiling and Clinical Characterization of Phototoxicity
Studies of Skin Microflora in Healthy Individuals and Atopic Dermatitis Patients
海外基金